The impact of an evidence-based, structured, and objective drug assessment approach for formulary inclusion of proton pump inhibitors in qatar
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: AL-BADRIYEH, Daoud (College of Pharmacy, Qatar University, Doha, Qatar)
- Co-author(s): Fahey, Michael (Operation Department, Hamad Medical Corporation, Doha, Qatar)
Zaidan, Manal (Pharmacy Department, Hamad Medical Corporation, Doha, Qatar)
Alkhal, Abdullatif (Medicine Department, Hamad Medical Corporation, Doha, Qatar)
Background: No systematic evidence-based drug selection approach exists in Hamad Medical Corporation (HMC) - the main health provider in Qatar, which is creating confusion among practitioners when selecting from a variety of entities in several drug classes. The proton pump inhibitors (PPI) class is a good example of which.
Objective: To develop.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.